- Home
- KLIC vs IRON Comparison
KLIC vs IRON Comparison
Compare KLIC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- IRON
- Stock Information
- Founded
- KLIC 1951
- IRON 2017
- Country
- KLIC United States
- IRON United States
- Employees
- KLIC N/A
- IRON N/A
- Industry
- KLIC Semiconductors
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- KLIC Technology
- IRON Health Care
- Exchange
- KLIC Nasdaq
- IRON Nasdaq
- Market Cap
- KLIC 2.0B
- IRON 2.1B
- IPO Year
- KLIC N/A
- IRON N/A
- Fundamental
- Price
- KLIC $41.39
- IRON $87.23
- Analyst Decision
- KLIC Buy
- IRON Strong Buy
- Analyst Count
- KLIC 4
- IRON 13
- Target Price
- KLIC $45.00
- IRON $102.23
- AVG Volume (30 Days)
- KLIC 445.9K
- IRON 623.6K
- Earning Date
- KLIC 11-12-2025
- IRON 11-11-2025
- Dividend Yield
- KLIC 2.01%
- IRON N/A
- EPS Growth
- KLIC N/A
- IRON N/A
- EPS
- KLIC 0.11
- IRON N/A
- Revenue
- KLIC $657,842,000.00
- IRON N/A
- Revenue This Year
- KLIC N/A
- IRON N/A
- Revenue Next Year
- KLIC $18.61
- IRON N/A
- P/E Ratio
- KLIC $357.60
- IRON N/A
- Revenue Growth
- KLIC N/A
- IRON N/A
- 52 Week Low
- KLIC $26.63
- IRON $30.82
- 52 Week High
- KLIC $52.08
- IRON $95.95
- Technical
- Relative Strength Index (RSI)
- KLIC 57.10
- IRON 70.58
- Support Level
- KLIC $37.89
- IRON $83.52
- Resistance Level
- KLIC $40.23
- IRON $89.00
- Average True Range (ATR)
- KLIC 1.31
- IRON 3.75
- MACD
- KLIC -0.00
- IRON 0.93
- Stochastic Oscillator
- KLIC 100.00
- IRON 69.65
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.